Pistis, Marco
 Distribuzione geografica
Continente #
AS - Asia 726
NA - Nord America 666
EU - Europa 244
SA - Sud America 155
Continente sconosciuto - Info sul continente non disponibili 48
AF - Africa 17
OC - Oceania 7
Totale 1.863
Nazione #
US - Stati Uniti d'America 640
SG - Singapore 354
BR - Brasile 128
CN - Cina 98
IT - Italia 91
HK - Hong Kong 87
VN - Vietnam 85
NL - Olanda 51
FR - Francia 38
BD - Bangladesh 31
IN - India 21
CA - Canada 12
GB - Regno Unito 11
FI - Finlandia 8
JP - Giappone 8
CO - Colombia 7
EC - Ecuador 7
TR - Turchia 7
DE - Germania 6
KR - Corea 6
MX - Messico 6
ES - Italia 5
TN - Tunisia 5
AU - Australia 4
IQ - Iraq 4
LT - Lituania 4
PL - Polonia 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
AR - Argentina 3
AT - Austria 3
CL - Cile 3
ID - Indonesia 3
IE - Irlanda 3
MA - Marocco 3
NZ - Nuova Zelanda 3
RU - Federazione Russa 3
UA - Ucraina 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
JM - Giamaica 2
KE - Kenya 2
LV - Lettonia 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
VE - Venezuela 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
RS - Serbia 1
SE - Svezia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 1.815
Città #
Santa Clara 222
Singapore 196
San Jose 114
Hong Kong 81
Ashburn 53
Beijing 36
Ho Chi Minh City 35
Lauterbourg 33
Los Angeles 31
Cagliari 22
Hanoi 19
Rome 14
Hefei 12
São Paulo 11
Tokyo 8
Council Bluffs 7
Belo Horizonte 5
Buffalo 5
Chennai 5
Denver 5
Helsinki 5
New York 5
Chicago 4
Montreal 4
Orem 4
Seoul 4
Shanghai 4
Tunis 4
Verona 4
Ankara 3
Charlotte 3
Cleveland 3
Dallas 3
Dublin 3
Frankfurt am Main 3
Houston 3
Lappeenranta 3
London 3
Ludhiana 3
Milan 3
Naples 3
New Delhi 3
Paris 3
Piscataway 3
Rio de Janeiro 3
Santiago 3
Sydney 3
Toronto 3
Warsaw 3
Aprilia 2
Atlanta 2
Auckland 2
Baku 2
Baltimore 2
Bologna 2
Boston 2
Brasília 2
Brooklyn 2
Bắc Giang 2
Campinas 2
Carapicuíba 2
Castel Maggiore 2
Erbil 2
Goiânia 2
Greenwood 2
Guanambi 2
Guangzhou 2
Guarulhos 2
Ha Long 2
Haiphong 2
Huntsville 2
Hải Dương 2
Istanbul 2
Johannesburg 2
Joinville 2
Kingston 2
Merrick 2
Mexico City 2
Miami 2
Middletown 2
Minneapolis 2
Montevideo 2
Newnan 2
North Charleston 2
Oklahoma City 2
Pelotas 2
Philadelphia 2
Phoenix 2
Phủ Lý 2
Poplar 2
Porto Alegre 2
Prato 2
Quito 2
Riga 2
Riyadh 2
Saginaw 2
Salvador 2
San Francisco 2
Santa Luzia 2
St Petersburg 2
Totale 1.114
Nome #
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance 66
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 65
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 64
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPAR-alpha Agonist Fenofibrate-Treated Mice 63
The PPAR alpha agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 58
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 56
The Atypical Dopamine Transporter Inhibitor CE-158 Enhances Dopamine Neurotransmission in the Prefrontal Cortex of Male Rats: A Behavioral, Electrophysiological, and Microdialysis Study 56
Maternal Immune Activation and the Endocannabinoid System: Focus on Two-Hit Models of Schizophrenia 54
Oltre gli endocannabinoidi: ruolo dei neuromodulatori lipidici nelle tossicodipendenze 52
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 52
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlates 51
Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus 51
delta 9 Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 50
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases 50
Functional Adaptation in the Brain Habenulo–Mesencephalic Pathway During Cannabinoid Withdrawal 49
Stereoselectivity of NCS-382 binding to γ-hydroxybutyrate receptor in the rat brain 48
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function 47
PPAR modulation of mesolimbic dopamine transmission rescues depression-related behaviors 46
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 44
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 44
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice 43
PPAR-Alpha Agonists as Novel Antiepileptic Drugs: Preclinical Findings 43
Adolescent D9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats 43
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome. 41
Maternal immune activation disrupts dopamine system in the offspring 41
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 36
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 35
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 34
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 34
Identification of metabolic biomarkers of chronic vagus nerve stimulation (VNS) in subjects with drug‐resistant epilepsy (DRE) 34
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 33
Endocannabinoids and the processing of value-related signals. 33
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 32
Braking dopamine systems: A new GABA master structure for mesolimbic and nigrostriatal functions 31
PPAR? regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving ?7 nicotinic acetylcholine receptors 31
Hub and switches: Endocannabinoid signalling in midbrain dopamine neurons 31
Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. 30
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 30
Anandamide and 2-arachidonoylglycerol: Pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids 28
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister hooded rats 26
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major 26
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: Preclinical findings 24
. Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings 20
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-? gene (PPARA) and schizophrenia 18
null 11
null 9
Totale 1.863
Categoria #
all - tutte 7.341
article - articoli 7.004
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 337
Totale 14.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025774 1 6 46 23 202 11 62 40 60 52 158 113
2025/2026993 21 55 68 139 190 57 194 40 51 76 34 68
2026/202796 62 34 0 0 0 0 0 0 0 0 0 0
Totale 1.863